ArticleTheranostics2023
Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 38 citations in OpenAlex.
- Extracellular vesicles in senescence-associated chronic lung diseases.Chinese medical journal · 2026Review
- mCancer science · 2026Article
- Integrin α5β1 in pancreatic ductal adenocarcinoma: Tumour‒stroma crosstalk, hypoxia and therapeutic targeting.Clinical and translational medicine · 2026Review
- TLCD1 correlates with malignant progression of hepatocellular carcinoma and activation of the ERK signaling cascade.Scientific reports · 2026Article
- CASK promotes non-small cell lung cancer growth through coordinated regulation of EGFR expression, trafficking, and p21 expression.Journal of biomedical science · 2026Article
- GMFB promotes lung adenocarcinoma progression by activating the MAPK/ERK signaling pathway.Molecular and cellular biochemistry · 2026Article
- Mechanism of ITGB2 in Osteoclast Differentiation in Osteoarthritis.Cell proliferation · 2026Article
- Isoleucine and valine regulate the BCAA antagonism by influencing insulin function in broiler chickens.Journal of animal science and biotechnology · 2026Article
- Atlas-Guided Nanocarrier Strategies Targeting Spatial NTRK2/MAPK Signaling in EGFR-TKI-Resistant Niches of Esophageal Squamous Cell Carcinoma.Pharmaceutics · 2026Review
- Spatiotemporally programmed hybrid nano-prodrugs orchestrate multidimensionally synergistic cascade lethality in NSCLC.Theranostics · 2026Article
- Integrated methylome analysis identifies an epigenetically silenced tumor suppressor RASA4 in small cell lung cancer.Communications biology · 2025Article
- An electrochemiluminescence immunosensor for neuron-specific enolase detection based on resonance energy transfer between europium-based metal-organic frameworks and GO-Au composites.Mikrochimica acta · 2025Article
- Immunotherapy for small cell lung cancer: current challenges and prospects.Experimental hematology & oncology · 2025Review
- ITGAV as a promising diagnostic, immunological, and prognostic biomarker in pan-cancer.Scientific reports · 2025Article
- TMEM16A inhibition suppresses melanoma metastasis.Acta biochimica et biophysica Sinica · 2025Article
- ncRNA-mediated ITGB1 upregulation correlates with poor prognosis and tumor-immune infiltration in gastric cancer.European journal of medical research · 2025Article
- Hydrogel-embedded precision-cut lung slices support ex vivo culture of in vivo-induced premalignant lung lesions.Physiological reports · 2025Article
- Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome.Nature communications · 2025Article
- Redox regulation: mechanisms, biology and therapeutic targets in diseases.Signal transduction and targeted therapy · 2025Review
- Insights into the mechanisms of angiogenesis in hepatoblastoma.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 11 institutions in 5 countries.
Karla RubioUniversité de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365; F-54000 Nancy, France.
Addi J Romero-OlmedoLung Cancer Epigenetics, Max-Planck-Institute for Heart and Lung Research; 61231 Bad Nauheim, Germany.
Pouya SarvariIndependent Researcher, collaborator of International Laboratory EPIGEN-CONCYTEP.
Guruprasadh SwaminathanUniversité de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365; F-54000 Nancy, France.
Vikas P RanvirEmmy Noether Research Group Epigenetic Machineries and Cancer, Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Diana G Rogel-AyalaUniversité de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365; F-54000 Nancy, France.
Julio CorderoDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Stefan GüntherECCPS Bioinformatics and Deep Sequencing Platform, Max-Planck-Institute for Heart and Lung Research; 61231 Bad Nauheim, Germany.
Aditi MehtaLung Cancer Epigenetics, Max-Planck-Institute for Heart and Lung Research; 61231 Bad Nauheim, Germany.
Birgit BassalyInstitute for Pathology, Justus Liebig University; 35392 Gießen, Germany.
Peter BraubachInstitute for Pathology, Hannover Medical School; Hanover, Germany.
Malgorzata WygreckaCenter for Infection and Genomics of the Lung (CIGL), Universities of Giessen and Marburg Lung Center; Giessen, Germany.
Stefan GattenlöhnerInstitute for Pathology, Justus Liebig University; 35392 Gießen, Germany.
Achim TreschCECAD, University of Cologne; Cologne, Germany.
Thomas BraunDepartment of Cardiac Development, Max-Planck-Institute for Heart and Lung Research; 61231 Bad Nauheim, Germany.
Gergana DobrevaDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Miguel N RiveraDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School; Charlestown, MA, 02129, USA.
Indrabahadur SinghEmmy Noether Research Group Epigenetic Machineries and Cancer, Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Johannes GraumannBiomolecular Mass Spectrometry, Max-Planck-Institute for Heart and Lung Research; 61231 Bad Nauheim, Germany.
Guillermo BarretoUniversité de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365; F-54000 Nancy, France.
Centre National de la Recherche Scientifique · FRMax Planck Institute for Heart and Lung Research · DEGerman Cancer Research Center · DEHeidelberg University · DEJustus-Liebig-Universität Gießen · DEPhilipps University of Marburg · DEGerman Center for Lung Research · DEMassachusetts General Hospital · USMedizinische Hochschule Hannover · DEMNEPU Academy · RUUniversity of Cologne · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Lung NeoplasmsSmall Cell Lung CarcinomaErbB ReceptorsHumansIntegrinsMutationRetrospective StudiesEGFR protein, humanErbB ReceptorsIntegrinsEGFRextracellular vesiclesintegrinKRASsmall cell lung cancer
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.